Since E-cadherin is a major component in the motility circuit activated during EMT [19], the impact of miR-126 and miR-218 on motility and invasion was determined in DCIS-derived cells treated with mimics or inhibitors. Here, CDH1 is linked to ductal breast carcinoma in situ.